Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 17Recruiting 10Unknown 8Withdrawn 3Not yet recruiting 3Terminated 2Active not recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Anorexia Nervosa with Significantly Low Body Weight 1

Interventions

Cisplatin 9Standard of Care 6Educational Status 6Nivolumab 5Interviews as Topic 5Carboplatin 5Radiotherapy 4Paclitaxel 4Oxaliplatin 4Dexamethasone 4pembrolizumab 3camrelizumab 3Practice Guidelines as Topic 3Patient Navigation 3Methods 3Magnetic Resonance Spectroscopy 3Magnetic Resonance Imaging 3Lenalidomide 3Fluorouracil 3Fluorodeoxyglucose F18 3Exercise 3Early Intervention, Educational 3Drug Therapy 3Cytarabine 3130-nm albumin-bound paclitaxel 3venetoclax 2toripalimab 2tislelizumab 2sacituzumab govitecan 2lenvatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Interventional × Olanzapine × Clear all
NCT05170919 2024-09-19

Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer

Englewood Hospital and Medical Center

Phase 2 Enrolling by invitation
170 enrolled

Anorexia Nervosa with Significantly Low Body Weight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡